International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 2
March-April 2026
Indexing Partners
Uterine Fibroids
| Author(s) | Ms. Sanjana, Ms. Nidhi |
|---|---|
| Country | India |
| Abstract | BACKGROUND AND OBJECTIVES: Uterine fibroids(also known as leiomyomas and myomas) are most common non-cancerous tumors that mainly affects the smooth muscles of the uterus, with highly spreadable in older women. Leiomyomas can occuring at any age of the women but leiomyoma is mostly develop in 25-40% of women of generative age; however there are different results are seen from different population. The pathogenesis of uterine fibroids is not yet well known. The main aim of this review was to estimates the probable connection between the use of pills and takes place of leiomyomas in women of generative age. Myomas symptoms include abnormal bleeding during mensuration leading to anaemia, tiredness, urinary retention, back pain constipartion, and discomfort in lower abdomen pregnancy loss and other consequences. It's aslo included with reproductive problems like impaired fertility, complication and adverse effect outcomes. In addition to more then 250,000 supracervical hysterectomies, in excess of 35,000 fibroidectomy and 20,000-30,000 of leiomyomas embolizations and other procedures are performed for symptomatic leiomyomas per years in the india. Thirty percents of the reproductive women dealing with the symptoms of leiomyomas and between them, around 37% needed to hospitalisation due to the serverity of the disease. The myomas treatments included supplements with iron, birth control hormones remedies, painkillers, drugs modulating the estrogen receptors, gonadotropin-releasing hormone agonists and surgery for the removal of uterine fibroids. In 2025, the estimated healthcare costs of myomas in private hospital are varied from 55,000 to 60,000 in india. |
| Keywords | uterine fibroids, contraceptive pills, supracervical hysterectomies. |
| Field | Medical / Pharmacy |
| Published In | Volume 7, Issue 6, November-December 2025 |
| Published On | 2025-11-11 |
| DOI | https://doi.org/10.36948/ijfmr.2025.v07i06.59431 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals